纳米脂质载体 (NLCs):在药物输送中的潜力和承诺
Sunil Bharti1, Gajanand Sharma2, Amita Sarwal1
1University Institute of Pharmaceutical Sciences, UGC Centre of Advance Studies, Panjab University, Chandigarh 160014, India.
Critical reviews in therapeutic drug carrier systems
|February 13, 2026
概括
纳米结构脂质载体 (NLCs) 为通过皮肤传递药物提供了一个有前途的解决方案,克服了皮肤屏障的挑战. 这些安全的,可生物降解的载体增强药物加载和释放,为有效的局部和全身治疗提供帮助.
科学领域:
- 制药科学 制药科学
- 纳米技术 纳米技术
- 材料科学 材料科学 材料科学
背景情况:
- 通过皮肤递送药物绕过了第一通代谢并改善了患者的服药性.
- 皮肤屏障对有效的药物透具有重大挑战.
- 纳米结构脂质载体 (NLCs) 是比固体脂质纳米粒子 (SLNs) 的一个进步.
研究的目的:
- 为通过皮肤应用提供NLC的全面概述.
- 讨论NLC的组成,生产和评估.
- 探索NLC在本地和全身药物输送方面的潜力.
主要方法:
- 审查NLC的类型,配方策略和表征技术.
- 对NLCs通过皮肤层的透机制的分析.
- 检查最近的进展,专利和工业可扩展性.
主要成果:
- 与SLN相比,NLC提供了增强的稳定性,更高的药物负载和受控释放.
- NLC 显示了克服皮肤屏障局限性的潜力.
- 显著的研究和专利活动凸显了对NLCs日益增长的兴趣.
结论:
- NLCs是安全的,可生物降解的纳米载体,具有通过皮肤递送药物的巨大潜力.
- 通过NLC可以解决在实现有效的局部和全身透皮治疗方面的挑战.
- 对标准化和扩展的进一步研究对于临床翻译至关重要.
相关概念视频
Site-Targeted Drug Delivery Systems: Polymeric Carriers
16
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
16
Electron Carriers
92.2K
Electron carriers can be thought of as electron shuttles. These compounds can easily accept electrons (i.e., be reduced) or lose them (i.e., be oxidized). They play an essential role in energy production because cellular respiration is contingent on the flow of electrons.
Over the many stages of cellular respiration, glucose breaks down into carbon dioxide and water. Electron carriers pick up electrons lost by glucose in these reactions, temporarily storing and releasing them into the electron...
Over the many stages of cellular respiration, glucose breaks down into carbon dioxide and water. Electron carriers pick up electrons lost by glucose in these reactions, temporarily storing and releasing them into the electron...
92.2K
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
4
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
4
Drug Delivery: Overview
925
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
925
What are Lipids?
221.4K
Overview
221.4K
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
6.3K
Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
6.3K


